External site

By following this link, you are leaving Medically and entering a website that is not owned or controlled by Roche. Roche does not take any responsibility for access to or use of this website, nor for any content therein.

Leave site
Home Cardiovascular AHA 2025
Roche and Genentech at

AHA 2025

November 07 - November 10
New Orleans, USA
aha-2025.org
Add to calendar
Share feedback
Share page
-
Medical Materials
Agenda
Coming soon
09:24 PM
Duration 8mins Clinical Science Zone 1
KARDIA-3: A randomized trial of zilebesiran versus placebo on top of standard care for patients with hypertension and established cardiovascular disease or high cardiovascular risk with or without chronic kidney disease
Neha Pagidipati
Cardiovascular | Hypertension

You have successfully signed up for this alert. You will be notified when it is available.

Sign up or login to unlock the full suite of MEDICALLY features
Add to calendar

This website is intended for healthcare professionals outside the United Kingdom (UK) and Australia. Registration status and prescribing information of medicinal products may differ between countries. Please refer to local product information for any medicinal products mentioned on this website.